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The Molecular Fingerprint of Dorsal
Root and Trigeminal Ganglion
Neurons
Douglas M. Lopes*†, Franziska Denk† and Stephen B. McMahon
Neurorestoration Group, Wolfson Centre for Age-Related Diseases, King’s College London, London, United Kingdom
The dorsal root ganglia (DRG) and trigeminal ganglia (TG) are clusters of cell bodies
of highly specialized sensory neurons which are responsible for relaying information
about our environment to the central nervous system. Despite previous efforts to
characterize sensory neurons at the molecular level, it is still unknown whether those
present in DRG and TG have distinct expression profiles and therefore a unique
molecular fingerprint. To address this question, we isolated lumbar DRG and TG
neurons using fluorescence-activated cell sorting from Advillin-GFP transgenic mice
and performed RNA sequencing. Our transcriptome analyses showed that, despite
being overwhelmingly similar, a number of genes are differentially expressed in DRG
and TG neurons. Importantly, we identified 24 genes which were uniquely expressed in
either ganglia, including an arginine vasopressin receptor and several homeobox genes,
giving each population a distinct molecular fingerprint. We compared our findings with
published studies to reveal that many genes previously reported to be present in neurons
are in fact likely to originate from other cell types in the ganglia. Additionally, our neuron-
specific results aligned well with a dataset examining whole human TG and DRG. We
propose that the data can both improve our understanding of primary afferent biology
and help contribute to the development of drug treatments and gene therapies which
seek targets with unique or restricted expression patterns.
Keywords: DRG, trigeminal ganglia, RNA sequencing, transcriptome, pain, migraine
INTRODUCTION
Among the different types of cells present in the central (CNS) and peripheral (PNS) nervous
systems, sensory neurons are of particular importance as they are continually relaying information
about our environment. The trigeminal ganglion (TG) contains many of the sensory neurons
innervating the head while the dorsal root ganglia (DRG) mostly innervate the rest of the
body. Both groups are highly specialized pseudounipolar neurons that can detect and respond
to a variety of chemical, mechanical, and thermal stimuli, serving as a warning system for
mammals (Porter and Spencer, 1982; Luo et al., 1991; Capra and Dessem, 1992; Devor, 1999;
Abbreviations: Avil, advillin; AVRG, average; CGRP, calcitonin gene-related peptide; DRG, dorsal root ganglia; FACS,
fluorescence-activated cell sorting; FPKM, Fragments Per Kilobase of transcript per Million mapped reads; GFP or EGFP,
(enhanced) green fluorescent protein; Hox, homeobox; mRNA, messenger RNA; PI, propidium iodide; qPCR, quantitative
polymerase chain reaction; RIN, RNA integrity number; RNA, ribonucleic acid; RNA-seq, RNA sequencing; TG, trigeminal
ganglia.
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Woolf and Ma, 2007; Dubin and Patapoutian, 2010). TG neurons,
in addition, have some distinct chemosensitive properties relating
to olfaction and the gustatory system (Gerhold and Bautista,
2009; Viana, 2011).
DRG and TG are formed by agglomerates of many thousands
of primary afferent neurons. There is large heterogeneity,
whereby different types of neurons have their own special
perceptual modalities and therefore distinct cellular and
molecular identities (Snider and McMahon, 1998; Devor, 1999;
Marmigere and Ernfors, 2007; Dubin and Patapoutian, 2010;
Reichling et al., 2013). Despite their functional similarities and
capability to sense innocuous and noxious stimuli, DRG and
TG neurons are very distinct in their location and connectivity.
DRG afferents are found peripherally alongside the spinal cord
and directly synapse onto spinal neurons, whereas TG neurons
are localized at the base of the skull, projecting either directly
to the brain stem or to the upper regions of the spinal cord
(Capra and Dessem, 1992; Erzurumlu et al., 2010). Moreover,
DRG neurons derive from the neural crest, whereas TG neurons
have dual origin, containing cells originated both from cranial
neural crest and trigeminal ectodermal placodes (Altman and
Bayer, 1982; D’Amico-Martel and Noden, 1983; Durham and
Garrett, 2010; Erzurumlu et al., 2010; Krispin et al., 2010). The
distinction in cell fate at embryonic stages, together with some
of the already mentioned exclusive functional characteristics and
different connectivity patterns, suggests the existence of different
molecular identities underlying either of these ganglia.
Studies have indeed started to characterize DRG and TG
neurons at the molecular level using RNA sequencing (RNA-seq)
(Manteniotis et al., 2013; Chiu et al., 2014; Perkins et al., 2014;
Thakur et al., 2014; Flegel et al., 2015; Reynders et al., 2015;
Hu et al., 2016; Sapio et al., 2016; Wu et al., 2016; Kogelman
et al., 2017) enabling in-depth analysis and characterization of
their genome-wide transcriptional profiles. To date a few studies
have reported approximately 200 differentially expressed genes
in both rodents and humans (Manteniotis et al., 2013; Flegel
et al., 2015; Kogelman et al., 2017). Among them were many
odorant-binding proteins, ion channels, and G protein-coupled
receptors (Manteniotis et al., 2013; Flegel et al., 2015). However,
non-neuronal cells account for a significant proportion of cells in
these ganglia (Devor, 1999; Hanani, 2005; Durham and Garrett,
2010; Huang et al., 2013) and therefore influence the transcripts
present in these datasets, with neuronal genes underrepresented.
Thus, a comparison in the expression profiles between enriched
neuronal cell populations remains to be performed.
In this study, we examined lumbar DRG and TG ganglia with
a specific focus on differences in neuronal gene expression. Using
a combination of fluorescence-activated cell sorting (FACS), a
transgenic mouse model and RNA-seq analysis, we identified a
number of genes exclusively expressed in either DRG or TG
neurons. Furthermore, we correlated our data with published
studies and reveal that many genes previously believed to be
present in neurons, are in fact either expressed in glial cells or
other cell types. These findings are not only important for the
understanding of the biology of primary afferents as whole, but
could also aid development of drug treatments and gene therapies
which seek unequivocal targets.
RESULTS
Isolation of Specific Populations of
Neurons by FACS
We have previously demonstrated that conventional DRG
dissociation results in a mixture of cells in which neurons only
account for ∼10% of the population (Thakur et al., 2014). In
this study we used a sorting strategy, employing a mouse line
expressing GFP under the control of the advillin promotor
(Avil-GFP), which labels sensory neurons (Gong et al., 2003)
(Figure 1A and Supplementary Figure 1). Lumbar DRG and TG
were dissociated, the cells were exposed to propidium iodide (PI)
and isolated using FACS (Figure 1B; for gating strategies, please
refer to section “Materials and Methods” and Supplementary
Figure 2). From all GFP+/PI− singlets, 500 events were captured
for each biological replicate consisting of n= 6 mice for DRG and
n = 4 mice for TG. Culture and analysis of sorted cells revealed
that despite limited satellite glial cells, neurons accounted for over
70% of our isolated population (data not shown), a percentage we
estimate to be slightly undervalued, given the proliferating nature
of non-neuronal cells.
RNA-Sequencing of DRG and TG
Neurons
Following the isolation of neurons by FACS, high-quality RNA
was extracted (average RIN 8.75, min 7.6, max 9.9) and
RNA-seq was performed on polyA+ mRNA using six DRG
and four TG replicates. Between 20.7 and 30.3 million reads
were uniquely aligned to the mm10 genome using STAR (Dobin
et al., 2013), corresponding to a median mapping percentage
of 85.8%. Normalized gene expression values and differential
gene expression were generated using the cuﬄinks and DESeq2
algorithms (Trapnell et al., 2010; Love et al., 2014), respectively.
Power calculations (using RNAPower; Hart et al., 2013) indicated
that we were well-powered to detect twofold differences in gene
expression (71% chance for all genes and 81–87% chance for the
top 50% of all expressed genes).
A total of 12,638 genes were detected in either DRG or
TG neurons (FPKM > 1, in at least two of the replicates for
each condition, Supplementary Table 1). Our DRG and TG data
were strongly correlated with the ranked expression profiles of
pure DRG nociceptors (Thakur et al., 2014): Spearman’s rho
rs = 0.65, Figure 2 and Supplementary Table 2. Correlations
are very sensitive to library batch effects and further depend on
the number and expression levels of the gene sets included in
the analysis. We therefore also conducted presence/absence calls,
which again showed good overlap: 80% of the top 8000 genes were
identified as present in both our current RNA-seq study and the
DRG nociceptors dataset (Supplementary Table 2).
Next, we looked for differences between our DRG and
TG samples. DESeq2 analysis revealed 97 genes that were
differentially expressed at adjusted p-value (adj. p) < 0.05
(Figures 3A,B), which means that the great majority of genes
(more than 99%) were commonly expressed. Of the genes which
were different, 44 were upregulated in DRG neurons and 19 were
upregulated in TG neurons, with 24 of the genes being present
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FIGURE 1 | Sensory neurons in the Avil-GFP transgenic mouse and schematic representation of neuronal isolation using flow cytometry. (A) Representative picture
of DRG and TG ganglion showing the expression of EGFP under the control of the advillin promoter (green cells) in sensory neurons. Scale bar: 50 µm. (B) Lumbar
DRG and TG were extracted from Avil-EGFP mice. Neurons were dissociated and exposed to propidium iodide (PI), and EGFP+ cells (neurons) were sorted using
the gating strategy above, where the non-neuronal cells and PI+ cells were excluded (represented in the cartoon as gray and red). RNA was then extracted and
sequenced.
exclusively in either ganglia (Table 1). Surprisingly, the vast
majority of the latter were homeobox genes (Hox), accounting
for ∼50% of the upregulated genes in the DRG (Figure 3B and
Table 1). Further to these neuronal genes, an additional 34 genes
emerging from DESeq2 analysis were either not deemed to be
expressed according to our FPKM expression cut-off or were not
of unambiguously neuronal origin (Supplementary Table 1). The
latter was determined by using a previously published RNA-seq
dataset (Thakur et al., 2014) in which DRG neurons were
magnetically sorted, which prevents any contamination with
satellite glial cells (see instruction sheet/tab of Supplementary
Table 1 for further information).
Validation of Differentially Expressed
Genes
Given the identification of several differentially expressed genes
between DRG and TG neurons in our dataset, we next went on to
validate genes with potential functional relevance to pain states.
Calcitonin gene-related peptide—CGRP (encoded by the gene
CALCA)—is primarily expressed by sensory neurons and known
to play a key role in inflammation and neuronal sensitization,
particularly during nerve damage (Donnerer and Stein, 1992;
Benemei et al., 2009; Yu et al., 2009; Russell et al., 2014) as
well as in migraine (Diener et al., 2015; Karsan and Goadsby,
2015; Edvinsson, 2017; Iyengar et al., 2017). Our transcriptome
analysis revealed a large difference of approximately 2.5-fold
increased expression of the CGRP gene in DRG in relation to TG
neurons (AVRG FPKM DRG: 8216 and TG: 3430; adj. p < 0.05;
Figure 4A). To validate this finding we performed a CGRP
ELISA from samples extracted from DRG and TG neurons.
Results showed that whole DRG has significantly higher level of
CGRP protein (Figure 4B); indeed, total CGRP levels were over
threefold higher when compared to TG (n = 4/group; p < 0.01;
Figure 4B). We also carried out qPCR, where we showed a higher
amount of CGRP mRNA in the DRG in an independent cohort
of animals (n= 3 DRG; n= 4 TG; p= 0.056; Figure 5A).
In addition to CGRP, our RNA-seq data also show a differential
expression of 15 Hox genes, all of which were exclusively
expressed in DRG extracted from the lumbar region. To verify
these findings, we performed qPCR in DRG and TG ganglia
from a separate cohort of animals. Our results revealed Hoxa7
mRNA to be present only in lumbar DRGs but not in TG neurons
(Figure 5B, n= 3 DRG; n= 4 TG; p< 0.01). As a positive internal
control, we probed for the Ntrk1 gene (TrkA) and, confirming
our RNA-seq analysis, found no difference between the groups
(Figure 5C).
Comparison between Mouse and Human
Datasets
Next, to characterize the similarity between the molecular profiles
generated from mouse and human TG, we compared our data to
the work of Flegel and collaborators (Flegel et al., 2015). 12,317
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FIGURE 2 | Expression profiles of mouse trigeminal neurons were well
correlated with other, previously published datasets. Ranked FPKM values for
mouse TG neurons obtained in this dataset are plotted against ranked FPKM
values of three different comparison datasets: mouse DRG neurons obtained
as part of this particular study (A, Spearman’s rs = 0.97), magnetically sorted
DRG neurons obtained by Thakur et al. (2014) (B, Spearman’s rs = 0.64) and
whole human TG data obtained by Flegel et al. (2015) (C, Spearman’s
rs = 0.53). Solid lines indicate linear correlations. Note that within study
correlations are necessarily higher than between study correlations due to the
absence of technical batch effects stemming, e.g., from separate library
preparation. See Supplementary Table 2 for the underlying data and for
additional graphs of presence/absence calls.
genes were found to be expressed in either dataset, 90% of which
were identified as equally present or absent in mouse and human
(Supplementary Table 2). Rank correlations were moderate
(Spearman’s rho rs = 0.53, Figure 2 and Supplementary Table 2).
Of the 63 differentially expressed neuronal genes identified in
our rodent DRG–TG data, almost 70% followed the same trend
toward up- or downregulation in the human data set (Figure 6
and Supplementary Table 3). Of the genes consistently regulated
across species, 21 showed at least a twofold higher FPKM in
human DRG compared to TG, while five showed a twofold
increase in TG. Together, these analyses demonstrate the validity
of our newly generated data and confirm the high molecular
similarities between mouse and human sensory ganglia.
DISCUSSION
Our study is the first to provide a molecular profile of enriched
TG and DRG neurons. Isolation of cells by FACS, followed by
high throughput sequencing demonstrated key differences in
expression level between neuron-specific genes in TG and DRG,
among them ion channels as well as genes reportedly involved in
pain processing. We validated our results in independent cohorts
at message and protein level. Finally, we could demonstrate
consistency between our newly generated RNA-seq and a
previously published dataset examining whole human TG and
DRG.
Studies to date have yielded significant insight into the cell
biology of both TG and DRG, giving a clear idea of fiber
demography, function, ratio, and distribution of myelinated
and non-myelinated fibers in each of these ganglia, as well
as how they contribute to nociception, pain, and migraine
(Snider and McMahon, 1998; Woolf and Ma, 2007; Dubin and
Patapoutian, 2010; DaSilva and DosSantos, 2012; Akerman et al.,
2017; Goadsby et al., 2017). However, relatively little is known
about the molecular characteristics of these distinct neuronal
populations, and how they compare at the transcriptional level.
Our data revealed that, despite distinct embryogenic origin and
processing capabilities, DRG and TG are surprisingly similar,
with an almost identical molecular fingerprint. Nevertheless, we
could identify 63 genes which were differentially expressed in
these two primary neuron populations, including 24 genes that
were found exclusively in either of the ganglia (Table 1).
Our results are somewhat unexpected, especially when
considering the highly specialized olfactory properties unique
to the TG ganglia. Indeed, in a recent study, Manteniotis
and collaborators identified almost 200 genes as differentially
expressed between whole DRG and TG (Manteniotis et al., 2013).
The group described the presence of a number of TG-specific
genes and hypothesized their involvement in olfactory processing
(Manteniotis et al., 2013). Our results, however, show that none
of the genes listed by the authors—including Olfr420, Gm14744,
and Lcn3—are expressed by isolated neurons. We believe the
contrasting results might be due to tissue composition, given that
the majority of cells after DRG dissociation are non-neuronal
(Thakur et al., 2014). This can lead to misinterpretation
of RNA-seq data: neuron-specific genes could appear falsely
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FIGURE 3 | Differential expression of trigeminal versus dorsal root ganglion transcripts. (A) Volcano plot of differentially expressed genes obtained using Deseq2.
Colored dots represent genes that were significantly dysregulated at FDR < 0.05. Genes upregulated in trigeminal ganglion are depicted in light (log2FC > 0) and
dark blue (log2FC > 1). Genes upregulated in dorsal root ganglion are depicted in light (log2FC < 0) and dark pink (log2FC < –1). Note that this graph includes
genes which are not expressed according to our cut-off as well as those which are enriched in satellite glial cells (see Supplementary Table 1). (B) The 44
unambiguously neuronal genes that were found to be upregulated in dorsal root ganglion at FDR < 0.05 were fed into a protein–protein interaction analysis. The
resulting network is depicted here and includes 28 genes, 50% of which were Hox genes.
downregulated if one type of ganglion were to contain a higher
proportion of non-neuronal cells.
Similarly, differences in myelin composition or resident
macrophage populations are visible and likely prominent in
transcriptional datasets comparing whole DRG and TG. A good
example is Kirrel2, which was initially described to be exclusively
expressed in TG ganglia (Manteniotis et al., 2013), but is in fact
not present in pure TG neurons. Rather, it is highly expressed by
astrocytes and oligodendrocytes (Zhang et al., 2014), suggesting
differential expression in the satellite glia or myelin of TG
and DRG. Similarly, the calcium channels subunits Cacna1g
and Cacna1s, which were proposed to be exclusively present
in DRG (Manteniotis et al., 2013), are in fact absent from
DRG neurons, as shown by our data and previously published
work (Thakur et al., 2014; Usoskin et al., 2015). Instead, these
genes are found to be expressed in other cells such as microglia
and macrophages, both in the CNS and PNS (Gosselin et al.,
2014; Lavin et al., 2014; Zhang et al., 2014; Denk et al., 2016),
suggesting the non-neuronal origin of these transcripts. Notably,
our results and analyses are not disputing the identity of genes
previously reported as exclusive to the TG or DRG. We are
only providing novel insight into which gene differences are
likely to be of neuronal origin. In this context, it is also
important to bear in mind that our dissociation method will
favor medium and small diameter neurons over large diameter
neurons (Supplementary Figure 3). Indeed, genes like Hcn2 and
Cacna2d4, which according to single cell data are likely to be
exclusively expressed in large diameter DRG neurons (Usoskin
et al., 2015; Li et al., 2016), do not pass our FPKM expression
cut-off.
The identification of differentially expressed genes allows for
the manipulation and targeting of neuronal subpopulations. Here
we show a remarkable difference in the expression of the CGRP
gene (CALCA) in the two types of ganglia. CGRP is well known
for its role as vasodilator and plays a central role in peripheral
sensitization, hyperalgesia, and migraine (Benemei et al., 2009;
Russell et al., 2014; Iyengar et al., 2017; Schou et al., 2017). Our
dataset confirms the presence of CGRP in both TG and DRG
neurons, with the latter having over twofold higher expression
of this gene—a result which is in line with RNA-seq data derived
from human samples (Flegel et al., 2015). These molecular data
may seem counterintuitive at first glance. Migraine patients have
elevated levels of CGRP (Karsan and Goadsby, 2015; Edvinsson,
2017; Iyengar et al., 2017), the reduction of which has repeatedly
been shown to constitute a promising treatment avenue (Olesen
et al., 2004; Diener et al., 2015; Karsan and Goadsby, 2015;
Mitsikostas and Rapoport, 2015). In contrast, chronic pain
conditions involving other areas of the body do not appear
to be alleviated by modulation of CGRP (Schou et al., 2017).
Yet, DRG appear to express much higher RNA message levels.
The discrepancy becomes less jarring when one considers that
nerve injury models which cause neuropathic pain conditions are
commonly reported to cause downregulation of CGRP (LaCroix-
Fralish et al., 2011; Reinhold et al., 2015). This suggests that the
gene may be implicated in divergent mechanistic processes in
cranial versus peripheral pain conditions.
Another finding from our dataset is the differential regulation
of the acid-sensing ion channel subtype-1 (ASIC1), which we
identified to have higher expression in TG versus DRG neurons.
In addition to having been implicated in neurite outgrowth,
neuronal differentiation, synaptic plasticity, learning, memory
as well as neuronal injury (Huang et al., 2013; Deval and
Lingueglia, 2015; Liu et al., 2017), ASIC1 has a well-documented
link to mechanoreception, nociception, and pain (Deval and
Lingueglia, 2015; Omerbasic et al., 2015). Previous studies also
indicated that ASIC1 could be an analgesic target during pain
states (Mazzuca et al., 2007; Diochot et al., 2012). Most notably,
ASIC1 has recently been shown to be a new potential drug
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TABLE 1 | Genes exclusively expressed in either ganglia, identified by RNA
sequencing.
Exclusive expression
Gene ID Gene name DRG Trigeminal
ENSMUSG00000020123 Avpr1a X
ENSMUSG00000038112 AW551984 X
ENSMUSG00000063415 Cyp26b1 X
ENSMUSG00000029054 Gabrd X
ENSMUSG00000078706 Gm53 X
ENSMUSG00000043219 Hoxa6 X
ENSMUSG00000038236 Hoxa7 X
ENSMUSG00000038227 Hoxa9 X
ENSMUSG00000000938 Hoxa10 X
ENSMUSG00000048763 Hoxb3 X
ENSMUSG00000038700 Hoxb5 X
ENSMUSG00000000690 Hoxb6 X
ENSMUSG00000038721 Hoxb7 X
ENSMUSG00000001661 Hoxc6 X
ENSMUSG00000001657 Hoxc8 X
ENSMUSG00000036139 Hoxc9 X
ENSMUSG00000022484 Hoxc10 X
ENSMUSG00000027102 Hoxd8 X
ENSMUSG00000043342 Hoxd9 X
ENSMUSG00000050368 Hoxd10 X
ENSMUSG00000028033 Kcnq5 X
ENSMUSG00000049112 Oxtr X
ENSMUSG00000005268 Prlr X
ENSMUSG00000026475 Rgsl6 X
Table listing 24 genes which were exclusively present in the DRG (21 genes) and TG
(three genes). First column shows the ENSEMBL Code ID for the gene; the second
column lists the gene name and the third/fourth columns display the restrictive
expression of the gene either in the DRG or TG (tick marks). Note that the vast
majority of the genes are Hox genes. Differential expression was calculated using a
Wald test with DESeq2. Exclusivity was considered when FPKM was ≥1 in one
neuronal population and not present (FPKM < 1) in the other population, and
expression was not depleted in pure neurons (refer to Supplementary Table 1 for
additional information).
target for migraine (Holland et al., 2012; Dussor, 2015). Our
results are directly relevant to these findings, as we show
that expression of the ASIC1 gene is notably higher in TG
neurons when compared to DRG. Moreover, we newly identified
ASIC1 as differentially expressed compared to previous datasets
(Manteniotis et al., 2013; Flegel et al., 2015), likely because its
presence in oligodendrocytes (Zhang et al., 2014) would have
obscured the neuron-specific difference in mixed tissues. This
again highlights the importance of studying cell populations in
isolation, as dilution effects can obscure crucial targets that might
be used in clinic.
Besides genes linked to pain processing, our study also
identified 15 Hox genes which are exclusively expressed in lumbar
DRG neurons compared to TG. Hox genes are recognized for
their key role as regulators of system development and cell fate
specification during embryogenesis (Wellik, 2007; Mallo and
Alonso, 2013; Philippidou and Dasen, 2013). Their continued
presence in adult DRG is the most striking difference between the
two types of ganglia: it can be detected at the level of whole TG
FIGURE 4 | Validation of selected targets. (A) CGRP mRNA (Calca) was
found to be significantly upregulated in our RNA-seq dataset. Plotted here are
individual FPKM values, including means and standard errors of the means.
(B) CGRP ELISA showed significantly increased protein levels in the DRG
versus the TG of a separate cohort of mice: n = 4, independent samples t-test
(two-tailed, heteroscedastic), p = 0.005.
and DRG (Manteniotis et al., 2013; Flegel et al., 2015; Kogelman
et al., 2017), and similar anterior–posterior patterns are still
discernible in adult CNS (Hutlet et al., 2016). In the brain, the
expression of Hox genes after development has been linked to the
regulation of key proteins that are involved in synapse formation
and plasticity (Hutlet et al., 2016). Evidence is still sparse, but if
it were to consolidate, Hox genes could represent an interesting
exploratory drug target for some forms of chronic pain where
changes in synaptic plasticity are well-recognized (Luo et al.,
2014; Kuner and Flor, 2016). The absence of Hox genes from
the TG is likely due to the distinctive pattern of homeobox gene
expression during development (Hodge et al., 2007). We propose
that, in the near future, these unique genes could also be used
as “guides” in gene therapy, to either knockdown or overexpress
genes in specific neurons during chronic pain states, as it has
been proposed and already achieved in some specific cell types
(Jang et al., 2007; Waehler et al., 2007; Clarke and McMillan,
2014).
Unveiling the specific molecular identities of sensory neurons
is crucial for understanding the biology of these highly specialized
cells under healthy conditions as well as for developing effective
therapies in disease. This is the first report of a molecular
comparison between enriched DRG and TG neurons. Our
RNA-seq analyses show that despite unexpected similarity,
these two populations of neurons have some unique molecular
characteristics, as evinced by 63 differentially expressed genes.
We are confident that our results will benefit the scientific
community by providing easily searchable, neuron-specific
information on DRG and TG expression patterns. Furthermore,
good agreement between mouse neurons and human tissue
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FIGURE 5 | qPCR validation of differentially expressed genes. (A) Similarly to the RNA-seq dataset, CGRP mRNA (Calca) was higher in the DRG when compared to
TG (#p = 0.056). (B) Hoxa7 gene is exclusively expressed in DRG neurons (∗∗∗p < 0.001), (C) whereas TrkA (Ntrk1) is equally expressed across the two groups of
neurons (p > 0.05). Results shown are from samples extracted from a separate cohort of mice: n = 3 DRG and n = 4 TG. Plotted here are individual ddCT values
normalized to GAPDH, including means and standard errors of the means; p-values were obtained using a Mann–Whitney test.
suggests that our analyses may aid in the continued quest for
better drugs against chronic pain conditions, including migraine.
MATERIALS AND METHODS
Transgenic Mice
Avil-GFP mice [see gensat.org: STOCK Tg (Avil-EGFP)
QD84Gsat/Mmucd for BAC expression levels] were bred
in-house for several generations on a CD1 background. In
all experiments, adult, age-matched (3–6 months) littermate
controls from both genders were used. Mice were kept in a 12-h
light–dark cycle, with food and water ad libitum. All experiments
were performed in accordance with the UK Animals (Scientific
Procedures) Act 1986 and Local Ethical Committee approval.
Fluorescence-Activated Cell Sorting
Avil-GFP mice were deeply anesthetized with pentobarbital
and transcardially perfused with 10 ml of PBS. TG (two
ganglia/animal) or lumbar DRG (L1–L5, n = 10 lumbar
ganglia/animal) were dissected out. Samples were then incubated
in 3 mg/ml dispase, 0.1% collagenase and 200 U/ml DNase
for 60 min at 37◦C in a CO2 incubator, followed by gentle
trituration in 1 ml of FACS buffer (5% trehalose, 0.05 mM
APV, 15 mM HEPES in DPBS). PI (2.5 µg/ml) was added to
the cell suspension so dead cells could be identified during
sorting.
Following dissociation, neuronal cell isolation was performed
using a BD FACS Aria II Cell Sorter at the NIHR BRC flow
core facility at King’s College London (nozzle size 100 µM). Cell
populations were gated on GFP+, PI− signal with the help of
unstained and single-staining controls. For every experiment,
cells from a non-transgenic control animal were used for
compensation controls. Positive events (500/animal) were sorted
directly into Qiagen RLT buffer and beta-mercaptoethanol and
stored at −80◦C until the entirety of the biological samples
were collected and processed for RNA extraction using a
RNeasy Micro kit (Qiagen) with minor modifications of the
manufacturer’s protocol. Sample quality was confirmed on
an Agilent Bioanalyzer (average RIN value of 8.75, min 7.6,
max 9.9).
Sequencing
RNA-seq was performed as previously described (Thakur et al.,
2014). In brief, samples were sent for batch-controlled library
preparation (SMARTer Ultra Low Input HV kit, 634820,
Clontech) and sequencing at the High-Throughput Genomics
Group at the Wellcome Trust Centre for Human Genetics
at Oxford University. Following amplification, samples were
multiplexed in replicate flow cells on an Illumina HiSeq 4000
platform. Reads were uniquely aligned to the mm10 genome
using STAR (Dobin et al., 2013), yielding a median mapping
percentage of 85.8% (min 80.7%, max 87.6%, standard mapping
parameters, bar—outFilterMultimapNmax 1). Normalized gene
expression values and differential gene expression data were
generated using the cuﬄinks and DESeq2 algorithms (Trapnell
et al., 2010; Love et al., 2014), respectively. We applied an FPKM
expression cut-off, based on the underlying distribution of our
cuﬄinks data: FPKM ≥ 1 in at least two of the replicates for each
condition. Please note that expression cut-offs will be specific to
each individual RNA-seq dataset (as FPKM values are modeled
on a curve) and are necessarily somewhat arbitrary. Ours is quite
liberal and will likely overestimate the presence of particular gene
transcripts. Raw and processed data are available under GEO
accession GSE100175.
ELISA
CGRP (Calca) protein levels were measured from freshly
extracted DRG and TG samples using a CGRP ELISA
kit according to manufacturer’s instructions (Bertin Pharma,
589001). Briefly, the tissue was macerated with a hand-held
homogenizer in 200 µl EIA buffer, and the resultant protein was
bound by anti-CGRP antibody for 5 min at room temperature.
Samples were washed five times and the signal developed
with Ellman’s reagent and read on an ELISA plate reader
(Molecular Devices, 410 nM). All samples, standards and
negative controls were processed in duplicate. The resulting
standard curve was linear as required (y = 0.004x + 0.0973,
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FIGURE 6 | Interspecies comparison of differentially expressed neuronal
transcripts in mouse and whole ganglion transcripts in human. Of the 63
genes found to be differentially expressed in DRG and TG, 50 could also be
easily identified in a dataset examining expression in human (Flegel et al.,
2015). Depicted here is a standardized heatmap of the average log2 (FPKM)
values from the two different datasets. Blue indicates negative values, i.e.,
FPKM < 1, with the genes likely lowly expressed or absent. Increasing levels
of expression are represented by increasing degrees of red. See
Supplementary Table 3 for the underlying raw FPKM values.
R2 = 0.98), and all samples fell within the limits of the standard
samples.
qRT-PCR
Animals were deeply anesthetized with pentobarbital and
transcardially perfused with PBS. DRG (lumbar, L3–L6) and TG
were collected and RNA was prepared with the RNeasy Micro
kit (Qiagen). Total RNA (500 µg) was converted to cDNA using
the SuperScript R© III Reverse Transcriptase kit (Thermo Fisher
Scientific). Quantitative real-time PCR (qPCR) was performed
in duplicate with a SYBR green master mix (Roche Diagnostics
Limited) with the addition of the selected gene primer sequences
(Sigma)—see below. 1Cts were calculated in relation to a house
keeping gene (GAPDH). In all experiments, qPCR reactions
were run in a Roche Lightcycler 480 PCR machine. Results
were analyzed by the standard 11Ct method. All primers were
checked for their efficiency and specificity beforehand.
Cgrp_F: CTGAGGGCTCTAGCTTGGAC;
Cgrp_R: TGCCAAAATGGGATTGGTGG
Hoxa7_F: CAGTTTCCGCATCTACCCCT;
Hoxa7_R: CGTCTGGTAGCGCGTGT
TrkA_F: GAAGAATGTGACGTGCTGGG;
TrkA_R: GAAGGAGACGCTGACTTGGA
Gapdh_F: GGTCCCAGCTTAGGTTCATCA;
Gapdh_R: CCAATACGGCCAAATCCGTTC
Imaging
Avil-GFP mice were deeply anesthetized with pentobarbital and
transcardially perfused with PBS followed by a 4% PFA solution.
Tissue was dissected out (DRG and TG), post fixed for 2 h
and placed in 30% sucrose solution and left overnight at 4◦C.
Samples were then embedded in OCT and cut on a cryostat
(10 µm sections). Slides were incubated with blocking buffer
(10% donkey serum, 0.02% Triton X-100 in PBS), for ∼6 h
at room temperature. Sections were then incubated with anti-
NeuN antibody (1:1000; Rabbit—Millipore) overnight at room
temperature. Primary antibody was removed by washing with
PBS, three times. Secondary antibody conjugated with Alexa 594
(Invitrogen) was diluted in the blocking buffer (1:1000), and
slides were incubated for at least 2 h at room temperature. Slides
were then mounted using Fluoromount-G R© medium (Southern
Biotechnology) and allowed to dry for 48 h. Endogenous EGFP
alongside with Alexa 594 from the sections were imaged using
the tile imaging mode (mosaic function) in a Zeiss 710 LSM Axio
Imager.Z2 Microscope, at 20×/0.8 DICII magnification. Images
were processed (stitched and scale bars placed) using the Zen
2012—Blue Edition software (Zeiss).
Statistics
For all the validation experiments, normality was confirmed by
Shapiro–Wilk test. If samples showed a normal distribution,
parametric tests were used, otherwise, samples were analyzed by
a non-parametric test.
For the CGRP ELISA assay experiments, an independent
samples t-test (two-tailed, heteroscedastic) was used. For the
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qPCR experiments, a Mann–Whitney non-parametric test was
performed.
Statistical analyses were performed using Prism 5 software or
SPSS.
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